L-Carnitine 216mg/10ml

Quickstart Highlights

L-Carnitine is an amino acid derivative essential for fatty acid transport into mitochondria, where it facilitates β-oxidation and energy production[1]. Subcutaneous administration bypasses intestinal conversion to trimethylamine-N-oxide (TMAO), a metabolite associated with cardiovascular concerns[4], while providing 100% bioavailability compared to 5–18% for large oral doses[3]. This educational protocol presents a once-daily subcutaneous approach optimized for insulin-syringe measurements.

Reconstitute: Add 2.0 mL bacteriostatic water → 100 mg/mL concentration (1 unit = 1 mg).
Typical daily range: 50–100 mg once daily (gradual titration); advanced protocols may use up to 200 mg.
Easy measuring: At 100 mg/mL, 1 unit = 0.01 mL = 1 mg on a U-100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 2–4 weeks; do not freeze reconstituted solution.

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

Standard / Gradual Approach (2.0 mL = 100 mg/mL)

Week	Daily Dose	Units (per injection) (mL)
Weeks 1–2	50 mg	50 units (0.50 mL)
Weeks 3–8	100 mg	100 units (1.0 mL)
Weeks 9–12	100 mg	100 units (1.0 mL)

Frequency: Inject once daily subcutaneously. This 2.0 mL reconstitution provides optimal concentration for convenient dosing: 100 mg maintenance dose = exactly 1.0 mL (100 units)[8]. For advanced protocols requiring 150–200 mg daily, doses above 1.0 mL may be split into two injections at different sites to improve comfort.

Reconstitution Steps

Reference-derived details for L-Carnitine 216mg/10ml.

Draw 2.0 mL bacteriostatic water (0.9% benzyl alcohol) with a sterile syringe.
Inject slowly down the vial wall to minimize foaming; avoid direct stream onto powder.
Gently swirl or roll the vial until powder is fully dissolved (do not shake vigorously).
Label vial with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Use within 2–4 weeks; bacteriostatic water preservative inhibits microbial growth during multi-dose use[6]. Open source

Supplies Needed

Plan based on an 8–16 week daily protocol using 100 mg maintenance dose (most common). If starting with 50 mg titration (Weeks 1–2), subtract ~3–4 vials from totals below.

Peptide Vials (L-Carnitine, 200 mg each):Note: Each 200 mg vial reconstituted at 2.0 mL provides two 100 mg doses (or four 50 mg doses).
Peptide Vials (L-Carnitine, 200 mg each):Note: Each 200 mg vial reconstituted at 2.0 mL provides two 100 mg doses (or four 50 mg doses).: 8 weeks (56 days @ 100 mg/day) ≈ 28 vials
Peptide Vials (L-Carnitine, 200 mg each):Note: Each 200 mg vial reconstituted at 2.0 mL provides two 100 mg doses (or four 50 mg doses).: 12 weeks (84 days @ 100 mg/day) ≈ 42 vials
Peptide Vials (L-Carnitine, 200 mg each):Note: Each 200 mg vial reconstituted at 2.0 mL provides two 100 mg doses (or four 50 mg doses).: 16 weeks (112 days @ 100 mg/day) ≈ 56 vials
Insulin Syringes (U-100, 1 mL capacity):
Insulin Syringes (U-100, 1 mL capacity):: Per week: 7 syringes (1/day)
Insulin Syringes (U-100, 1 mL capacity):: 8 weeks: 56 syringes
Insulin Syringes (U-100, 1 mL capacity):: 12 weeks: 84 syringes
Insulin Syringes (U-100, 1 mL capacity):: 16 weeks: 112 syringes
Bacteriostatic Water (10 mL bottles): Use 2.0 mL per vial for reconstitution.
Bacteriostatic Water (10 mL bottles): Use 2.0 mL per vial for reconstitution.: 8 weeks (28 vials): 56 mL → 6 × 10 mL bottles
Bacteriostatic Water (10 mL bottles): Use 2.0 mL per vial for reconstitution.: 12 weeks (42 vials): 84 mL → 9 × 10 mL bottles
Bacteriostatic Water (10 mL bottles): Use 2.0 mL per vial for reconstitution.: 16 weeks (56 vials): 112 mL → 12 × 10 mL bottles
Alcohol Swabs: One for vial stopper + one for injection site each day.
Alcohol Swabs: One for vial stopper + one for injection site each day.: Per week: 14 swabs (2/day)
Alcohol Swabs: One for vial stopper + one for injection site each day.: 8 weeks: 112 swabs → recommend 2 × 100-count boxes
Alcohol Swabs: One for vial stopper + one for injection site each day.: 12 weeks: 168 swabs → recommend 2 × 100-count boxes
Alcohol Swabs: One for vial stopper + one for injection site each day.: 16 weeks: 224 swabs → recommend 3 × 100-count boxes
Sharps Container: For safe disposal of used syringes and needles.

Protocol Overview

Concise summary of the once-daily subcutaneous regimen.

Goal: Support mitochondrial fatty acid oxidation and energy metabolism while avoiding TMAO production associated with oral dosing[4]. Open source
Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).
Dose Range: 50–100 mg daily with gradual titration; advanced protocols may use up to 200 mg daily.
Reconstitution: 2.0 mL per 200 mg vial (100 mg/mL) for precise 1:1 unit-to-milligram measurement.
Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw cycles.

Dosing Protocol

Suggested daily titration approach based on clinical literature.

Start: 50 mg daily for Weeks 1–2 to assess tolerance and monitor for injection-site reactions[8]. Open source
Maintenance: Increase to 100 mg daily from Week 3 onward; this is a reasonable maintenance dose for most research purposes[8]. Open source
Advanced: Up to 200 mg daily for robust experimental protocols, if clearly supported by research findings[8]. Open source
Frequency: Once per day subcutaneously (any consistent time; morning or pre-exercise commonly used).
Cycle Length: 8–12 weeks; optional extension to 16 weeks with continued monitoring.
Site Rotation: Rotate injection sites systematically (abdomen, thighs, upper arms) to prevent tissue irritation.

Storage Instructions

Proper storage preserves peptide stability and potency.

Lyophilized (unreconstituted): Store at −20 °C (−4 °F) or below in dry, dark conditions; minimize moisture exposure. Keep vial tightly sealed. Stable for months to years when frozen[13]. Open source
Reconstituted solution: Refrigerate at 2–8 °C (35.6–46.4 °F) immediately after mixing. Do not freeze reconstituted solution as this can degrade the peptide[8]. Open source
Stability timeline: With bacteriostatic water (0.9% benzyl alcohol), reconstituted L-Carnitine remains usable for 2–4 weeks when refrigerated[8][13]. Benzyl alcohol suppresses bacterial growth during multi-dose use[6]. Open source
Before use: Allow refrigerated vials to reach room temperature before opening to reduce condensation. Inspect solution before each use; discard if discolored or contains precipitates.
Avoid freeze–thaw cycles: Repeated freezing and thawing degrades peptide integrity; aliquot into smaller vials if long-term storage is needed[13]. Open source

Important Notes

Practical considerations for consistency, safety, and optimal results.

Sterile technique: Use new sterile insulin syringes for each injection; never reuse needles or syringes.
Site rotation: Rotate injection sites systematically (abdomen at least 2 inches from navel, outer thighs, upper arms) to reduce local irritation and prevent lipohypertrophy[11]. Open source
Injection speed: Inject slowly (over several seconds) to minimize discomfort; wait 5–10 seconds before withdrawing needle to prevent leakage[6]. Open source
Room temperature: Allow refrigerated solution to warm slightly (to room temperature) before injecting to reduce pain[6]. Open source
Documentation: Keep a log of daily dose, injection site, and any observations (tolerance, energy levels) to maintain consistency.
Sharps disposal: Immediately dispose of used needles and syringes in an approved sharps container; never recap needles by hand.

How This Works

L-Carnitine is a quaternary ammonium compound biosynthesized from lysine and methionine that plays a critical role in energy metabolism. It acts as an obligate cofactor for the carnitine palmitoyltransferase (CPT) enzyme system, which shuttles long-chain fatty acids across the inner mitochondrial membrane for β-oxidation[1]. This process is essential for ATP production from fat stores, particularly during prolonged exercise or caloric restriction.

Clinical and preclinical studies indicate L-Carnitine supplementation can enhance fat oxidation, reduce body weight, and improve exercise performance in certain populations[2][5]. A meta-analysis of 37 randomized controlled trials found approximately 2,000 mg/day oral L-Carnitine yields modest weight-loss effects (~1.2 kg), with diminishing returns above that dose[2].
Why subcutaneous over oral? Oral L-Carnitine has poor bioavailability (5–18% at high doses) due to saturable intestinal absorption[3]. Furthermore, unabsorbed carnitine is metabolized by gut bacteria into trimethylamine (TMA), which is converted to trimethylamine-N-oxide (TMAO) in the liver—a metabolite linked to increased cardiovascular risk[4][9]. Subcutaneous or intravenous administration provides 100% bioavailability and bypasses TMAO production, as demonstrated in animal models where parenteral L-Carnitine did not promote atherosclerosis unlike oral dosing[4].
In hemodialysis patients with carnitine deficiency, intravenous L-Carnitine (10–40 mg/kg after dialysis sessions) significantly increased plasma carnitine levels, reduced fatigue, and preserved exercise capacity over 24 weeks with excellent tolerability[5]. High-dose intravenous protocols (up to 50 mg/kg daily, ~3,500 mg for a 70 kg person) have been used safely in patients with metabolic disorders[8], indicating a wide therapeutic margin.

Potential Benefits & Side Effects

Observations from clinical and preclinical literature on L-Carnitine supplementation.

Enhanced fat metabolism: Facilitates mitochondrial fatty acid oxidation and ATP production from lipid stores[1]. Open source
Weight management: Meta-analysis shows modest weight loss (~1.2 kg average) and reduction in BMI with oral supplementation at ~2 g/day[2]. Open source
Exercise performance: May improve exercise capacity and reduce fatigue, particularly in carnitine-deficient populations[5]. Open source
Avoids TMAO production: Subcutaneous route bypasses gut bacterial conversion to TMAO, potentially reducing cardiovascular risk associated with oral dosing[4][9]. Open source
Energy support: Clinical studies in dialysis patients show reduced fatigue and improved well-being with parenteral L-Carnitine[5]. Open source
Injection-site reactions: Mild redness, swelling, or irritation at injection sites (typically transient). Rotate sites systematically to minimize[6]. Open source
Gastrointestinal effects (oral): High oral doses (>3 g/day) can cause nausea, diarrhea, and fishy body odor from metabolite accumulation[9]. Subcutaneous administration minimizes these effects by reducing required dose and avoiding first-pass gut metabolism[8]. Open source
Generally well-tolerated: Clinical trials report good safety profiles with parenteral L-Carnitine, even at high doses (up to 50 mg/kg IV daily)[5][8]. Open source
Note: This information is for educational purposes only. Individual responses may vary. Consult appropriate resources before beginning any supplementation protocol.

Lifestyle Factors

Complementary strategies to optimize L-Carnitine’s metabolic effects.

Balanced nutrition: Pair with a protein-forward diet (1.6–2.2 g/kg bodyweight) to support lean mass retention during fat loss. Ensure adequate essential amino acids (lysine and methionine) for endogenous carnitine synthesis[1]. Open source
Exercise synergy: Combine resistance training (3–5×/week) with aerobic activity (150+ min/week moderate intensity) to maximize fat oxidation and metabolic adaptations. L-Carnitine’s effects on fat metabolism are enhanced during exercise[2]. Open source
Caloric management: Create a modest caloric deficit (300–500 kcal/day) if fat loss is the goal. L-Carnitine does not override energy balance but may enhance fat utilization within a deficit[2]. Open source
Sleep optimization: Prioritize 7–9 hours of quality sleep nightly to support recovery, hormonal balance, and adherence to training/nutrition protocols.
Hydration: Maintain adequate fluid intake (minimum 2–3 liters/day, more with exercise) to support metabolic processes and overall health.
Stress management: Chronic stress elevates cortisol, which can impair fat loss and recovery. Incorporate stress-reduction practices (meditation, breathing exercises, adequate rest).

Injection Technique

Proper subcutaneous injection technique based on CDC guidelines and clinical best practices[11][12].

Hand hygiene: Wash hands thoroughly with soap and water or use alcohol-based hand sanitizer.
Materials: Gather sterile U-100 insulin syringe (1 mL capacity, 25–30 gauge needle), alcohol swabs, sharps container, and refrigerated L-Carnitine vial.
Warm vial: Allow vial to reach room temperature (or roll gently between palms) to reduce injection discomfort[6]. Open source
Vial prep: Swab rubber stopper with alcohol and allow to dry (~30 seconds).
Draw dose: Insert needle through stopper, draw prescribed volume (e.g., 100 units = 1.0 mL for 100 mg dose), and expel any air bubbles by tapping syringe and pushing plunger slightly.
Site selection: Choose a fatty subcutaneous area. Common sites include[11]: Open source
Site selection: Choose a fatty subcutaneous area. Common sites include[11]: - Abdomen (at least 2 inches away from navel) Open source
Site selection: Choose a fatty subcutaneous area. Common sites include[11]: - Outer thigh (middle third, avoiding inner thigh) Open source
Site selection: Choose a fatty subcutaneous area. Common sites include[11]: - Upper outer arm (triceps region, if sufficient subcutaneous tissue) Open source
Site rotation: Keep a rotation log to avoid using the same site within 1–2 weeks. This prevents lipohypertrophy and tissue damage[11]. Open source
Skin antisepsis: Clean injection site with alcohol swab using outward circular motion; allow to dry completely (~30 seconds).
Needle insertion: Pinch a fold of skin (1–2 inches) between thumb and forefinger. Insert needle at a 45° angle (or 90° if using very short needle and ample subcutaneous tissue) into the subcutaneous fat layer[11][12]. Open source
No aspiration needed: Aspiration (pulling back on plunger) is not necessary for subcutaneous injections, as there are no large blood vessels in subcutaneous tissue[11]. Open source
Inject slowly: Depress plunger steadily over 3–5 seconds to minimize discomfort. Injecting volumes <1.0 mL causes minimal pain; larger volumes (1.5–2.0 mL) may be split into two separate injections[6]. Open source
Wait before withdrawal: After full injection, wait 5–10 seconds before withdrawing needle to prevent solution leakage.
Needle removal: Withdraw needle at the same angle as insertion. Release skin pinch.
Pressure/bleeding: Apply gentle pressure with clean gauze or cotton ball if slight bleeding occurs (uncommon). Do not rub the injection site vigorously.
Sharps disposal: Immediately place used syringe and needle into an approved sharps container. Never recap needles or dispose in regular trash[12]. Open source
Documentation: Record date, time, dose, and injection site in your protocol log.
Inject solution at room temperature (not cold from refrigerator) to reduce pain[6]. Open source
Use fresh needles for each injection; dull or reused needles increase pain and infection risk.
Relax muscles at injection site; tension increases discomfort.
Benzyl alcohol in bacteriostatic water causes less injection pain than other preservatives (e.g., m-cresol)[6]. Open source

Recommended Source

We recommend Prime Lab Peptides for high-purity L-Carnitine (200 mg) with comprehensive quality documentation.

Third-party testing: Each batch includes Certificates of Analysis (COA) confirming purity ≥98% via HPLC and mass spectrometry.
Quality assurance: ISO-aligned handling, sterile manufacturing, and consistent cold-chain logistics ensure product integrity.
Transparent documentation: Batch-specific COAs, proper labeling, and reconstitution guidance provided with every order.
Reliable fulfillment: Fast shipping with appropriate cold packs/insulation to maintain stability during transit.
Research-grade: Manufactured specifically for laboratory research purposes with strict quality controls.

Important Note

This page is informational and does not authorize use. Peptify clients should complete assessment, disclose medications and health history, and follow the clinician-approved plan only.

Do not start, stop, combine, or change a protocol based only on website content.
Emergency symptoms require urgent medical care, not a website or routine follow-up message.

References